Caroline Schoenherr

Hannover, NI, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Combining inotuzumab ozogamicin with the p38 inhibitor BIRB 796 and venetoclax exerts synergistic cytotoxicity in B-cell precursor acute lymphoblastic leukemia including very high risk t(17;19) acute lymphoblastic leukemia.

Combining inotuzumab ozogamicin with the p38 inhibitor BIRB 796 and venetoclax exerts synergistic cytotoxicity in B-cell precursor acute lymphoblastic leukemia including very high risk t(17;19) acute lymphoblastic leukemia.

Journal: Haematologica
Published: January 14, 2026

Differential mitochondrial priming by BCR::ABL1 in B-cell precursor acute lymphoblastic leukemia.

Differential mitochondrial priming by BCR::ABL1 in B-cell precursor acute lymphoblastic leukemia.

Journal: Leukemia
Published: November 25, 2025

Combination of targeted pharmacotherapy and immunotherapy with anti-CD19 CAR NK cells in acute lymphoblastic leukemia.

Combination of targeted pharmacotherapy and immunotherapy with anti-CD19 CAR NK cells in acute lymphoblastic leukemia.

Journal: HemaSphere
Published: May 30, 2025

Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model.

Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model.

Journal: Frontiers in molecular medicine
Published: August 28, 2024

Venetoclax and dexamethasone synergize with inotuzumab ozogamicin-induced DNA damage signaling in B-lineage ALL.

Venetoclax and dexamethasone synergize with inotuzumab ozogamicin-induced DNA damage signaling in B-lineage ALL.

Journal: Blood
Published: August 04, 2020

Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase.

Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase.

Journal: PloS one
Published: September 09, 2019

miR-125b regulates chemotaxis and survival of bone marrow derived granulocytes in vitro and in vivo.

miR-125b regulates chemotaxis and survival of bone marrow derived granulocytes in vitro and in vivo.

Journal: PloS one
Published: May 16, 2018

Peptide microarray profiling identifies phospholipase C gamma 1 (PLC-γ1) as a potential target for t(8;21) AML.

Peptide microarray profiling identifies phospholipase C gamma 1 (PLC-γ1) as a potential target for t(8;21) AML.

Journal: Oncotarget
Published: February 21, 2017
Showing 1-8 of 8

Last Updated: 09/26/2026